Computational Biology Market Size, Trends and Forecast to 2032

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Computational Biology Market Size Analysis

Global Computational Biology Market Introduction
By Application
1. Introduction
  1. Application By Value
2. Cellular and Biological Simulation
  1. By Value
  2. Computational Genomics
    1. Computational Genomics By Value
  3. Computational Proteomics
    1. Computational Proteomics By Value
  4. Pharmacogenomics
    1. Pharmacogenomics By Value
  5. Other
    1. Other By Value
3. Drug Discovery and Disease Modeling
  1. By Value
  2. Target Identification
    1. Target Identification By Value
  3. Target Validation
    1. Target Validation By Value
  4. Lead Discovery
    1. Lead Discovery By Value
  5. Lead Optimization
    1. Lead Optimization By Value
4. Preclinical Drug Development
  1. By Value
  2. Pharmacokinetics
    1. Pharmacokinetics By Value
  3. Pharmacodynamics
    1. Pharmacodynamics By Value
5. Clinical Trials
  1. By Value
  2. Phase I
    1. Phase I By Value
  3. Phase II
    1. Phase II By Value
  4. Phase III
    1. Phase III By Value
6. Human Body Simulation Software
  1. By Value
By Tool
1. Introduction
  1. Tool By Value
2. Databases
  1. By Value
3. Infrastructure (Hardware)
  1. By Value
4. Analysis Software and Services
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. In-House
  1. By Value
3. Contract
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academics
  1. By Value
3. Industry and Commercials
  1. By Value

North America Market Analysis

Introduction
By Application
1. Introduction
  1. Application By Value
2. Cellular and Biological Simulation
  1. By Value
  2. Computational Genomics
    1. Computational Genomics By Value
  3. Computational Proteomics
    1. Computational Proteomics By Value
  4. Pharmacogenomics
    1. Pharmacogenomics By Value
  5. Other
    1. Other By Value
3. Drug Discovery and Disease Modeling
  1. By Value
  2. Target Identification
    1. Target Identification By Value
  3. Target Validation
    1. Target Validation By Value
  4. Lead Discovery
    1. Lead Discovery By Value
  5. Lead Optimization
    1. Lead Optimization By Value
4. Preclinical Drug Development
  1. By Value
  2. Pharmacokinetics
    1. Pharmacokinetics By Value
  3. Pharmacodynamics
    1. Pharmacodynamics By Value
5. Clinical Trials
  1. By Value
  2. Phase I
    1. Phase I By Value
  3. Phase II
    1. Phase II By Value
  4. Phase III
    1. Phase III By Value
6. Human Body Simulation Software
  1. By Value
By Tool
1. Introduction
  1. Tool By Value
2. Databases
  1. By Value
3. Infrastructure (Hardware)
  1. By Value
4. Analysis Software and Services
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. In-House
  1. By Value
3. Contract
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academics
  1. By Value
3. Industry and Commercials
  1. By Value
U.S.
1. By Application
  1. Introduction
    1. Application By Value
  2. Cellular and Biological Simulation
    1. By Value
    2. Computational Genomics
      1. Computational Genomics By Value
    3. Computational Proteomics
      1. Computational Proteomics By Value
    4. Pharmacogenomics
      1. Pharmacogenomics By Value
    5. Other
      1. Other By Value
  3. Drug Discovery and Disease Modeling
    1. By Value
    2. Target Identification
      1. Target Identification By Value
    3. Target Validation
      1. Target Validation By Value
    4. Lead Discovery
      1. Lead Discovery By Value
    5. Lead Optimization
      1. Lead Optimization By Value
  4. Preclinical Drug Development
    1. By Value
    2. Pharmacokinetics
      1. Pharmacokinetics By Value
    3. Pharmacodynamics
      1. Pharmacodynamics By Value
  5. Clinical Trials
    1. By Value
    2. Phase I
      1. Phase I By Value
    3. Phase II
      1. Phase II By Value
    4. Phase III
      1. Phase III By Value
  6. Human Body Simulation Software
    1. By Value
2. By Tool
  1. Introduction
    1. Tool By Value
  2. Databases
    1. By Value
  3. Infrastructure (Hardware)
    1. By Value
  4. Analysis Software and Services
    1. By Value
3. By Service
  1. Introduction
    1. Service By Value
  2. In-House
    1. By Value
  3. Contract
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Academics
    1. By Value
  3. Industry and Commercials
    1. By Value
Canada

Europe Market Analysis

Introduction
By Application
1. Introduction
  1. Application By Value
2. Cellular and Biological Simulation
  1. By Value
  2. Computational Genomics
    1. Computational Genomics By Value
  3. Computational Proteomics
    1. Computational Proteomics By Value
  4. Pharmacogenomics
    1. Pharmacogenomics By Value
  5. Other
    1. Other By Value
3. Drug Discovery and Disease Modeling
  1. By Value
  2. Target Identification
    1. Target Identification By Value
  3. Target Validation
    1. Target Validation By Value
  4. Lead Discovery
    1. Lead Discovery By Value
  5. Lead Optimization
    1. Lead Optimization By Value
4. Preclinical Drug Development
  1. By Value
  2. Pharmacokinetics
    1. Pharmacokinetics By Value
  3. Pharmacodynamics
    1. Pharmacodynamics By Value
5. Clinical Trials
  1. By Value
  2. Phase I
    1. Phase I By Value
  3. Phase II
    1. Phase II By Value
  4. Phase III
    1. Phase III By Value
6. Human Body Simulation Software
  1. By Value
By Tool
1. Introduction
  1. Tool By Value
2. Databases
  1. By Value
3. Infrastructure (Hardware)
  1. By Value
4. Analysis Software and Services
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. In-House
  1. By Value
3. Contract
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academics
  1. By Value
3. Industry and Commercials
  1. By Value
U.K.
1. By Application
  1. Introduction
    1. Application By Value
  2. Cellular and Biological Simulation
    1. By Value
    2. Computational Genomics
      1. Computational Genomics By Value
    3. Computational Proteomics
      1. Computational Proteomics By Value
    4. Pharmacogenomics
      1. Pharmacogenomics By Value
    5. Other
      1. Other By Value
  3. Drug Discovery and Disease Modeling
    1. By Value
    2. Target Identification
      1. Target Identification By Value
    3. Target Validation
      1. Target Validation By Value
    4. Lead Discovery
      1. Lead Discovery By Value
    5. Lead Optimization
      1. Lead Optimization By Value
  4. Preclinical Drug Development
    1. By Value
    2. Pharmacokinetics
      1. Pharmacokinetics By Value
    3. Pharmacodynamics
      1. Pharmacodynamics By Value
  5. Clinical Trials
    1. By Value
    2. Phase I
      1. Phase I By Value
    3. Phase II
      1. Phase II By Value
    4. Phase III
      1. Phase III By Value
  6. Human Body Simulation Software
    1. By Value
2. By Tool
  1. Introduction
    1. Tool By Value
  2. Databases
    1. By Value
  3. Infrastructure (Hardware)
    1. By Value
  4. Analysis Software and Services
    1. By Value
3. By Service
  1. Introduction
    1. Service By Value
  2. In-House
    1. By Value
  3. Contract
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Academics
    1. By Value
  3. Industry and Commercials
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Application
1. Introduction
  1. Application By Value
2. Cellular and Biological Simulation
  1. By Value
  2. Computational Genomics
    1. Computational Genomics By Value
  3. Computational Proteomics
    1. Computational Proteomics By Value
  4. Pharmacogenomics
    1. Pharmacogenomics By Value
  5. Other
    1. Other By Value
3. Drug Discovery and Disease Modeling
  1. By Value
  2. Target Identification
    1. Target Identification By Value
  3. Target Validation
    1. Target Validation By Value
  4. Lead Discovery
    1. Lead Discovery By Value
  5. Lead Optimization
    1. Lead Optimization By Value
4. Preclinical Drug Development
  1. By Value
  2. Pharmacokinetics
    1. Pharmacokinetics By Value
  3. Pharmacodynamics
    1. Pharmacodynamics By Value
5. Clinical Trials
  1. By Value
  2. Phase I
    1. Phase I By Value
  3. Phase II
    1. Phase II By Value
  4. Phase III
    1. Phase III By Value
6. Human Body Simulation Software
  1. By Value
By Tool
1. Introduction
  1. Tool By Value
2. Databases
  1. By Value
3. Infrastructure (Hardware)
  1. By Value
4. Analysis Software and Services
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. In-House
  1. By Value
3. Contract
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academics
  1. By Value
3. Industry and Commercials
  1. By Value
China
1. By Application
  1. Introduction
    1. Application By Value
  2. Cellular and Biological Simulation
    1. By Value
    2. Computational Genomics
      1. Computational Genomics By Value
    3. Computational Proteomics
      1. Computational Proteomics By Value
    4. Pharmacogenomics
      1. Pharmacogenomics By Value
    5. Other
      1. Other By Value
  3. Drug Discovery and Disease Modeling
    1. By Value
    2. Target Identification
      1. Target Identification By Value
    3. Target Validation
      1. Target Validation By Value
    4. Lead Discovery
      1. Lead Discovery By Value
    5. Lead Optimization
      1. Lead Optimization By Value
  4. Preclinical Drug Development
    1. By Value
    2. Pharmacokinetics
      1. Pharmacokinetics By Value
    3. Pharmacodynamics
      1. Pharmacodynamics By Value
  5. Clinical Trials
    1. By Value
    2. Phase I
      1. Phase I By Value
    3. Phase II
      1. Phase II By Value
    4. Phase III
      1. Phase III By Value
  6. Human Body Simulation Software
    1. By Value
2. By Tool
  1. Introduction
    1. Tool By Value
  2. Databases
    1. By Value
  3. Infrastructure (Hardware)
    1. By Value
  4. Analysis Software and Services
    1. By Value
3. By Service
  1. Introduction
    1. Service By Value
  2. In-House
    1. By Value
  3. Contract
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Academics
    1. By Value
  3. Industry and Commercials
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Application
1. Introduction
  1. Application By Value
2. Cellular and Biological Simulation
  1. By Value
  2. Computational Genomics
    1. Computational Genomics By Value
  3. Computational Proteomics
    1. Computational Proteomics By Value
  4. Pharmacogenomics
    1. Pharmacogenomics By Value
  5. Other
    1. Other By Value
3. Drug Discovery and Disease Modeling
  1. By Value
  2. Target Identification
    1. Target Identification By Value
  3. Target Validation
    1. Target Validation By Value
  4. Lead Discovery
    1. Lead Discovery By Value
  5. Lead Optimization
    1. Lead Optimization By Value
4. Preclinical Drug Development
  1. By Value
  2. Pharmacokinetics
    1. Pharmacokinetics By Value
  3. Pharmacodynamics
    1. Pharmacodynamics By Value
5. Clinical Trials
  1. By Value
  2. Phase I
    1. Phase I By Value
  3. Phase II
    1. Phase II By Value
  4. Phase III
    1. Phase III By Value
6. Human Body Simulation Software
  1. By Value
By Tool
1. Introduction
  1. Tool By Value
2. Databases
  1. By Value
3. Infrastructure (Hardware)
  1. By Value
4. Analysis Software and Services
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. In-House
  1. By Value
3. Contract
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academics
  1. By Value
3. Industry and Commercials
  1. By Value
UAE
1. By Application
  1. Introduction
    1. Application By Value
  2. Cellular and Biological Simulation
    1. By Value
    2. Computational Genomics
      1. Computational Genomics By Value
    3. Computational Proteomics
      1. Computational Proteomics By Value
    4. Pharmacogenomics
      1. Pharmacogenomics By Value
    5. Other
      1. Other By Value
  3. Drug Discovery and Disease Modeling
    1. By Value
    2. Target Identification
      1. Target Identification By Value
    3. Target Validation
      1. Target Validation By Value
    4. Lead Discovery
      1. Lead Discovery By Value
    5. Lead Optimization
      1. Lead Optimization By Value
  4. Preclinical Drug Development
    1. By Value
    2. Pharmacokinetics
      1. Pharmacokinetics By Value
    3. Pharmacodynamics
      1. Pharmacodynamics By Value
  5. Clinical Trials
    1. By Value
    2. Phase I
      1. Phase I By Value
    3. Phase II
      1. Phase II By Value
    4. Phase III
      1. Phase III By Value
  6. Human Body Simulation Software
    1. By Value
2. By Tool
  1. Introduction
    1. Tool By Value
  2. Databases
    1. By Value
  3. Infrastructure (Hardware)
    1. By Value
  4. Analysis Software and Services
    1. By Value
3. By Service
  1. Introduction
    1. Service By Value
  2. In-House
    1. By Value
  3. Contract
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Academics
    1. By Value
  3. Industry and Commercials
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Application
1. Introduction
  1. Application By Value
2. Cellular and Biological Simulation
  1. By Value
  2. Computational Genomics
    1. Computational Genomics By Value
  3. Computational Proteomics
    1. Computational Proteomics By Value
  4. Pharmacogenomics
    1. Pharmacogenomics By Value
  5. Other
    1. Other By Value
3. Drug Discovery and Disease Modeling
  1. By Value
  2. Target Identification
    1. Target Identification By Value
  3. Target Validation
    1. Target Validation By Value
  4. Lead Discovery
    1. Lead Discovery By Value
  5. Lead Optimization
    1. Lead Optimization By Value
4. Preclinical Drug Development
  1. By Value
  2. Pharmacokinetics
    1. Pharmacokinetics By Value
  3. Pharmacodynamics
    1. Pharmacodynamics By Value
5. Clinical Trials
  1. By Value
  2. Phase I
    1. Phase I By Value
  3. Phase II
    1. Phase II By Value
  4. Phase III
    1. Phase III By Value
6. Human Body Simulation Software
  1. By Value
By Tool
1. Introduction
  1. Tool By Value
2. Databases
  1. By Value
3. Infrastructure (Hardware)
  1. By Value
4. Analysis Software and Services
  1. By Value
By Service
1. Introduction
  1. Service By Value
2. In-House
  1. By Value
3. Contract
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Academics
  1. By Value
3. Industry and Commercials
  1. By Value
Brazil
1. By Application
  1. Introduction
    1. Application By Value
  2. Cellular and Biological Simulation
    1. By Value
    2. Computational Genomics
      1. Computational Genomics By Value
    3. Computational Proteomics
      1. Computational Proteomics By Value
    4. Pharmacogenomics
      1. Pharmacogenomics By Value
    5. Other
      1. Other By Value
  3. Drug Discovery and Disease Modeling
    1. By Value
    2. Target Identification
      1. Target Identification By Value
    3. Target Validation
      1. Target Validation By Value
    4. Lead Discovery
      1. Lead Discovery By Value
    5. Lead Optimization
      1. Lead Optimization By Value
  4. Preclinical Drug Development
    1. By Value
    2. Pharmacokinetics
      1. Pharmacokinetics By Value
    3. Pharmacodynamics
      1. Pharmacodynamics By Value
  5. Clinical Trials
    1. By Value
    2. Phase I
      1. Phase I By Value
    3. Phase II
      1. Phase II By Value
    4. Phase III
      1. Phase III By Value
  6. Human Body Simulation Software
    1. By Value
2. By Tool
  1. Introduction
    1. Tool By Value
  2. Databases
    1. By Value
  3. Infrastructure (Hardware)
    1. By Value
  4. Analysis Software and Services
    1. By Value
3. By Service
  1. Introduction
    1. Service By Value
  2. In-House
    1. By Value
  3. Contract
    1. By Value
4. By End-User
  1. Introduction
    1. End-User By Value
  2. Academics
    1. By Value
  3. Industry and Commercials
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Computational Biology Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Thermo Fisher Scientific Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Illumina, Inc.
Qiagen N.V.
Dassault Systemes SE
Certara
Chemical Computing Group ULC
Compugen Ltd
Rosa & Co. LLC
Genedata AG
Insilico Biotechnology AG
Instem Plc. (Leadscope Inc.)
Nimbus Discovery LLC
Strand Life Sciences

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment